What are the major opportunities in the Rubella Diagnostic Testing market? What are the strategies for the Rubella Diagnostic Testing market?

For detailed insights on the major opportunities and strategies in the Rubella Diagnostic Testing market, Read More

How does the Rubella Diagnostic Testing market relate to the overall economy and other similar markets?

For detailed insights on Rubella Diagnostic Testing's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Rubella Diagnostic Testing market growth? SWOT analysis of the Rubella Diagnostic Testing market.

For detailed insights on the key dynamics influencing the Rubella Diagnostic Testing market growth and SWOT analysis of the Rubella Diagnostic Testing industry, Read More

Rubella Diagnostic Testing Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Rubella Diagnostic Testing Market Report 2026

Name: Rubella Diagnostic Testing Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Diagnostic Technique (Latex Agglutination, Enzyme Immunoassay (EIA), Radioimmunoassay (Ria), Fluorescent Immunoassay (FIA), Other Diagnostic Techniques ), By Age Group (Neonates, Teenagers, Adults), By End User (Hospitals And Clinics, Diagnostic Laboratories, Public Health Laboratories, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Rubella Diagnostic Testing Market Overview

• Rubella Diagnostic Testing market size has reached to $1.39 billion in 2025

• Expected to grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%

• Growth Driver: The Rising Cases Of Viral Infections Propelling The Growth Of The Rubella Diagnostic Testing Market

• Market Trend: Innovative Solutions In Rubella Diagnostics And Vaccination

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Rubella Diagnostic Testing Market?

Rubella diagnostic testing refers to the methods used to detect the presence of rubella virus or antibodies in a patient's blood to confirm if they have been infected with rubella or have immunity against it. These tests help healthcare providers diagnose rubella accurately and manage its implications, especially in vulnerable populations.

The main types of diagnostic techniques in rubella diagnostic testing are latex aggregation, liver function tests, enzyme immunoassay (EIA), radioimmunoassay (Ria), fluorescent immunoassay (FIA), and others. Latex agglutination is a diagnostic method where tiny latex beads coated with rubella-specific antigens or antibodies are mixed with a patient’s sample. This technique is applicable across various age groups, including neonates, teenagers, and adults, and serves a range of end users such as hospitals and clinics, cancer diagnostic centers, ambulatory surgical centers, and others.

Rubella Diagnostic Testing Market Global Report 2026 Market Report bar graph

What Is The Rubella Diagnostic Testing Market Size and Share 2026?

The rubella diagnostic testing market size has grown strongly in recent years. It will grow from $1.39 billion in 2025 to $1.48 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to expansion of routine viral screening programs, increased awareness of congenital rubella syndrome, availability of serological testing kits, growth in diagnostic laboratory networks, adoption of immunoassay technologies.

What Is The Rubella Diagnostic Testing Market Growth Forecast?

The rubella diagnostic testing market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing investments in advanced diagnostic platforms, rising focus on maternal health screening, expansion of automated laboratory testing, growing adoption of point-of-care diagnostics, strengthening of infectious disease surveillance systems. Major trends in the forecast period include increasing adoption of molecular diagnostic techniques, rising use of pcr-based rubella testing, growing demand for prenatal screening, expansion of high-sensitivity immunoassays, enhanced focus on early disease detection.

Book your 30 minutes free consultation with our research experts

Global Rubella Diagnostic Testing Market Segmentation

1) By Diagnostic Technique: Latex Agglutination, Enzyme Immunoassay (EIA), Radioimmunoassay (Ria), Fluorescent Immunoassay (FIA), Other Diagnostic Techniques

2) By Age Group: Neonates, Teenagers, Adults

3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Public Health Laboratories, Other End Users

Subsegments:

1) By Latex Agglutination: Qualitative Latex Agglutination Tests, Quantitative Latex Agglutination Tests, Rapid Latex Agglutination Kits

2) By Enzyme Immunoassay (EIA): Direct EIA, Indirect EIA, Sandwich EIA, Competitive EIA

3) By Radioimmunoassay (RIA): Standard RIA, Modified RIA, Single-Antibody RIA

4) By Fluorescent Immunoassay (FIA): Direct FIA, Indirect FIA, Sandwich FIA

5) By Other Diagnostic Techniques: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAAT), Microplate-Based Assays, Western Blotting

What Is The Driver Of The Rubella Diagnostic Testing Market?

The rising cases of viral infections are expected to propel the growth of the rubella diagnostic testing market going forward. Viral infections are illnesses caused by viruses, tiny infectious agents that can only replicate inside the living cells of an organism. The rising cases of viral infections are due to increased global travel, which facilitates the spread of viruses across borders, and climate change, which alters vector habitats and extends the range of disease-carrying organisms. Rubella diagnostic testing helps identify and manage rubella infections early, preventing complications, particularly in pregnant women, and aiding in outbreak control to reduce virus spread. For instance, in December 2023, according to the National Health Service, a UK-based government department, the number of daily hospital admissions for flu averaged 234, marking a 53% increase from the previous week, while hospital cases of norovirus rose by 15% to an average of 406 daily, reflecting a 28% increase from the same week last year. Therefore, the rising cases of viral infections are driving the growth of the rubella diagnostic testing industry.

Key Players In The Global Rubella Diagnostic Testing Market

Major companies operating in the rubella diagnostic testing market are Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMérieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd., Sprint Diagnostics Pvt. Ltd., InDevR Inc., Atlas Medical GmbH

Global Rubella Diagnostic Testing Market Trends and Insights

Major companies operating in the rubella diagnostic testing market are focusing on developing innovative solutions, such as a rubella virus vaccine, to enhance diagnostic accuracy and improve preventive measures. The rubella virus vaccine is a vaccine that provides immunity against rubella, often administered as part of the MMR or MMRV combination vaccines to prevent the disease and associated complications. For instance, in March 2023, Merck & Co., Inc., a US-based pharmaceutical company, received FDA approval for the intramuscular (IM) administration of Merck’s M-M-R II vaccine, which is crucial in protecting against rubella, along with measles and mumps. This approval allows healthcare providers to administer the rubella vaccine using the IM route, making it consistent with other routinely recommended pediatric vaccines. Rubella vaccination is essential for preventing outbreaks and protecting against the severe complications the virus can cause, particularly in pregnant women.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Rubella Diagnostic Testing Market?

In September 2024, Leinco Technologies Inc., a US-based developer of high-purity antibodies, acquired QED Biosciences for an undisclosed amount. Through this acquisition, Leinco Technologies aims to expand its antibody product portfolio and development services, enhancing its life sciences and in vitro diagnostics capabilities while supporting its growth strategy and commitment to innovation and quality for global researchers. QED Biosciences is a US-based developer of novel monoclonal and polyclonal antibody products and offers rubella diagnostic testing services.

Regional Outlook

North America was the largest region in the rubella diagnostic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Rubella Diagnostic Testing Market?

The rubella diagnostic testing market consists of revenues earned by entities by providing services such as serological testing services, serologic tests, molecular diagnostic services, and rapid diagnostic testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The rubella diagnostic testing market also includes sales of serological assays, IgM antibodies, rapid diagnostic tests (RDTs), and polymerase chain reaction (PCR) tests. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Rubella Diagnostic Testing Market Report 2026?

The rubella diagnostic testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rubella diagnostic testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Rubella Diagnostic Testing Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.48 billion
Revenue Forecast In 2035	$1.89 billion
Growth Rate	CAGR of 6.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Diagnostic Technique, Age Group, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMérieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd., Sprint Diagnostics Pvt. Ltd., InDevR Inc., Atlas Medical GmbH
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Rubella Diagnostic Testing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Rubella Diagnostic Testing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Rubella Diagnostic Testing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Rubella Diagnostic Testing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Molecular Diagnostic Techniques

4.2.2 Rising Use Of Pcr-Based Rubella Testing

4.2.3 Growing Demand For Prenatal Screening

4.2.4 Expansion Of High-Sensitivity Immunoassays

4.2.5 Enhanced Focus On Early Disease Detection

5. Rubella Diagnostic Testing Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Laboratories

5.3 Ambulatory Surgical Centers

5.4 Public Health Laboratories

5.5 Research Institutes

6. Rubella Diagnostic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Rubella Diagnostic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Rubella Diagnostic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Rubella Diagnostic Testing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Rubella Diagnostic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Rubella Diagnostic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Rubella Diagnostic Testing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Rubella Diagnostic Testing Market Segmentation

9.1. Global Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Latex Agglutination, Enzyme Immunoassay (EIA), Radioimmunoassay (Ria), Fluorescent Immunoassay (FIA), Other Diagnostic Techniques

9.2. Global Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neonates, Teenagers, Adults

9.3. Global Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostic Laboratories, Public Health Laboratories, Other End Users

9.4. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Latex Agglutination, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Qualitative Latex Agglutination Tests, Quantitative Latex Agglutination Tests, Rapid Latex Agglutination Kits

9.5. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Enzyme Immunoassay (EIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct EIA, Indirect EIA, Sandwich EIA, Competitive EIA

9.6. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Radioimmunoassay (RIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Standard RIA, Modified RIA, Single-Antibody RIA

9.7. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Fluorescent Immunoassay (FIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct FIA, Indirect FIA, Sandwich FIA

9.8. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Other Diagnostic Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAAT), Microplate-Based Assays, Western Blotting

10. Rubella Diagnostic Testing Market Regional And Country Analysis

10.1. Global Rubella Diagnostic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Rubella Diagnostic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Rubella Diagnostic Testing Market

11.1. Asia-Pacific Rubella Diagnostic Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Rubella Diagnostic Testing Market

12.1. China Rubella Diagnostic Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Rubella Diagnostic Testing Market

13.1. India Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Rubella Diagnostic Testing Market

14.1. Japan Rubella Diagnostic Testing Market Overview

14.2. Japan Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Rubella Diagnostic Testing Market

15.1. Australia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Rubella Diagnostic Testing Market

16.1. Indonesia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Rubella Diagnostic Testing Market

17.1. South Korea Rubella Diagnostic Testing Market Overview

17.2. South Korea Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Rubella Diagnostic Testing Market

18.1. Taiwan Rubella Diagnostic Testing Market Overview

18.2. Taiwan Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Rubella Diagnostic Testing Market

19.1. South East Asia Rubella Diagnostic Testing Market Overview

19.2. South East Asia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Rubella Diagnostic Testing Market

20.1. Western Europe Rubella Diagnostic Testing Market Overview

20.2. Western Europe Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Rubella Diagnostic Testing Market

21.1. UK Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Rubella Diagnostic Testing Market

22.1. Germany Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Rubella Diagnostic Testing Market

23.1. France Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Rubella Diagnostic Testing Market

24.1. Italy Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Rubella Diagnostic Testing Market

25.1. Spain Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Rubella Diagnostic Testing Market

26.1. Eastern Europe Rubella Diagnostic Testing Market Overview

26.2. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Rubella Diagnostic Testing Market

27.1. Russia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Rubella Diagnostic Testing Market

28.1. North America Rubella Diagnostic Testing Market Overview

28.2. North America Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Rubella Diagnostic Testing Market

29.1. USA Rubella Diagnostic Testing Market Overview

29.2. USA Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Rubella Diagnostic Testing Market

30.1. Canada Rubella Diagnostic Testing Market Overview

30.2. Canada Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Rubella Diagnostic Testing Market

31.1. South America Rubella Diagnostic Testing Market Overview

31.2. South America Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Rubella Diagnostic Testing Market

32.1. Brazil Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Rubella Diagnostic Testing Market

33.1. Middle East Rubella Diagnostic Testing Market Overview

33.2. Middle East Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Rubella Diagnostic Testing Market

34.1. Africa Rubella Diagnostic Testing Market Overview

34.2. Africa Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Rubella Diagnostic Testing Market Regulatory and Investment Landscape

36. Rubella Diagnostic Testing Market Competitive Landscape And Company Profiles

36.1. Rubella Diagnostic Testing Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Rubella Diagnostic Testing Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Rubella Diagnostic Testing Market Company Profiles

36.3.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Rubella Diagnostic Testing Market Other Major And Innovative Companies

bioMérieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd.

38. Global Rubella Diagnostic Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Rubella Diagnostic Testing Market

40. Rubella Diagnostic Testing Market High Potential Countries, Segments and Strategies

40.1 Rubella Diagnostic Testing Market In 2030 - Countries Offering Most New Opportunities

40.2 Rubella Diagnostic Testing Market In 2030 - Segments Offering Most New Opportunities

40.3 Rubella Diagnostic Testing Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Rubella Diagnostic Testing Market, Overview Of Key Products - Product Examples

Table 2: Global Rubella Diagnostic Testing Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Rubella Diagnostic Testing Market, Supply Chain Analysis

Table 4: Global Rubella Diagnostic Testing Market, Major Raw Material Providers

Table 5: Global Rubella Diagnostic Testing Market, Major Resource Providers

Table 6: Global Rubella Diagnostic Testing Market, Major Manufacturers (Suppliers)

Table 7: Global Rubella Diagnostic Testing Market, Major Distributors And Channel Partners

Table 8: Global Rubella Diagnostic Testing Market, Key Technologies & Future Trends

Table 9: Global Rubella Diagnostic Testing Market, Major Trends

Table 10: Global Rubella Diagnostic Testing Market, Major End Users

Table 11: Global Rubella Diagnostic Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Rubella Diagnostic Testing Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Rubella Diagnostic Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Rubella Diagnostic Testing Market - TAM, US$ Billion, 2025

Table 15: Global Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Latex Agglutination, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Enzyme Immunoassay (EIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Radioimmunoassay (RIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Fluorescent Immunoassay (FIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Other Diagnostic Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Rubella Diagnostic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Rubella Diagnostic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Rubella Diagnostic Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Rubella Diagnostic Testing Market - Company Scoring Matrix

Table 99: Cardinal Health Inc. Financial Performance

Table 100: Siemens Healthineers AG Financial Performance

Table 101: Thermo Fisher Scientific Inc. Financial Performance

Table 102: Abbott Laboratories Financial Performance

Table 103: F. Hoffmann-La Roche Ltd Financial Performance

Table 104: Global Rubella Diagnostic Testing Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Rubella Diagnostic Testing Market, Competitive Dashboard

Table 106: Global Rubella Diagnostic Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Rubella Diagnostic Testing Market Size Gain ($ Billion), Segmentation By Diagnostic Technique, 2025 – 2030

Table 108: Global, Rubella Diagnostic Testing Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Table 109: Global, Rubella Diagnostic Testing Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Rubella Diagnostic Testing Market, Overview Of Key Products - Product Examples

Figure 2: Global Rubella Diagnostic Testing Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Rubella Diagnostic Testing Market, Supply Chain Analysis

Figure 4: Global Rubella Diagnostic Testing Market, Major Raw Material Providers

Figure 5: Global Rubella Diagnostic Testing Market, Major Resource Providers

Figure 6: Global Rubella Diagnostic Testing Market, Major Manufacturers (Suppliers)

Figure 7: Global Rubella Diagnostic Testing Market, Major Distributors And Channel Partners

Figure 8: Global Rubella Diagnostic Testing Market, Key Technologies & Future Trends

Figure 9: Global Rubella Diagnostic Testing Market, Major Trends

Figure 10: Global Rubella Diagnostic Testing Market, Major End Users

Figure 11: Global Rubella Diagnostic Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Rubella Diagnostic Testing Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Rubella Diagnostic Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Rubella Diagnostic Testing Market - TAM, US$ Billion, 2025

Figure 15: Global Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Latex Agglutination, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Enzyme Immunoassay (EIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Radioimmunoassay (RIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Fluorescent Immunoassay (FIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Other Diagnostic Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Rubella Diagnostic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Rubella Diagnostic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Rubella Diagnostic Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Rubella Diagnostic Testing Market - Company Scoring Matrix

Figure 99: Cardinal Health Inc. Financial Performance

Figure 100: Siemens Healthineers AG Financial Performance

Figure 101: Thermo Fisher Scientific Inc. Financial Performance

Figure 102: Abbott Laboratories Financial Performance

Figure 103: F. Hoffmann-La Roche Ltd Financial Performance

Figure 104: Global Rubella Diagnostic Testing Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Rubella Diagnostic Testing Market, Competitive Dashboard

Figure 106: Global Rubella Diagnostic Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Rubella Diagnostic Testing Market Size Gain ($ Billion), Segmentation By Diagnostic Technique, 2025 – 2030

Figure 108: Global, Rubella Diagnostic Testing Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Figure 109: Global, Rubella Diagnostic Testing Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Workstation Software Market Report 2026 - Global Outlook – By Type (Image And Video Processing Software, Virtual Reality Software, Computer Aided Design (CAD), Computer Aided Manufacturing (CAM), Computer Aided Engineeri...

Allogeneic T Cell Therapies Market Report 2026 - Global Outlook – By Product Type (Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies), By Antigen Type (CD 19, CD 20, Egfrvlll, GD2, CD22, C...

Hospital Acquired Infections Testing Kits Market Report 2026 - Global Outlook – By Product (Consumables And Reagents, Instruments), By Test Type (Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infec...

Microbiology Diagnostic Devices And Equipment Market Report 2026 - Global Outlook – By Type (Laboratory Instruments, Microbiology Analyzers, Reagents And Consumables), By Reagents (Pathogen-Specific Kits, General Reagent...

Travel And Expense Software Market Report 2026 - Global Outlook – By Component (Software, Services), By Deployment Model (Cloud Based, On Premise), By Organization Size (Small And Medium Enterprises (SMEs), Large Enterpr...

Thermal Systems Market Report 2026 - Global Outlook – By Component ( Air Filter, Condenser, Compressor, Water Pump, Motor, Heat Exchanger, Heater Control, Thermoelectric Generator, Other Components), By Vehicle ( Interna...

Acute Bacterial Skin And Skin Structure Infections Market Report 2026 - Global Outlook – By Type Of Infection (Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections, Community-Acquired Acute Bacterial Skin...

Frequently Asked Questions

How big is the Rubella Diagnostic Testing Market?

The Rubella Diagnostic Testing market was valued at $1.39 billion in 2025, increased to $1.48 billion in 2026, and is projected to reach $1.89 billion by 2030.

What is the Rubella Diagnostic Testing market growth?

The global Rubella Diagnostic Testing market is expected to grow at a CAGR of 6.4% from 2026 to 2035 to reach $1.89 billion by 2035.

Who are the key players in Rubella Diagnostic Testing market?

Some Key Players in the Rubella Diagnostic Testing market Include, Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMérieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical

Major trend in this market includes: Innovative Solutions In Rubella Diagnostics And Vaccination. For further insights on this market. request a sample here

North America was the largest region in the rubella diagnostic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rubella diagnostic testing market report are

Book your 30 minutes free consultation with our research experts

Contact Us